DIAMEDICA THERAPEUTICS INC.

EDGAR

Market value

$503.96M

53,957,474 shares as of 2026-11-09, at $9.34 a share (DMAC, IEX close on 2026-11-12) Primary-source evidence

66 filing records in this dataset, filed from 2018-11-09 to 2026-11-12. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
4 transactions, 450,650 shares
Sum of shares × price per share: 3,443,324.846
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-08-10 Pauls Dietrich John A 60,200 0
  • 2026-06-01 Semba Charles Pauling A 40,412 0
  • 2026-06-01 Krop Julie A 67,500 0
  • 2026-06-01 Kellen Scott A 162,000 0
  • 2026-06-01 Kuntz Richard A 40,412 0

5% holders (Schedule 13D and 13G)

  • Dialectic Life Sciences SPV LLC 0% SCHEDULE 13G/A 12/31/2025
  • Dialectic LS Manager LLC 0% SCHEDULE 13G/A 12/31/2025
  • Dialectic Capital Management, LP 0% SCHEDULE 13G/A 12/31/2025

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Cash and cash equivalents
6.8 million USD Source
Exact value

6800000 USD

Long-term debt including current maturities
Not available
Shares outstanding
54 million shares Source
Exact value

53957474 shares

Reported share-count change

3.61% · 1.88 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 52077439 shares · 2025-09-30· Source
  • 53957474 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-40.2 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -32766000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -24026000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -10042000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -10139000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -11310000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-33.8 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -29100000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -21297000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -9100000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -17200000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -9100000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -26000000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -17200000 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

27 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Capital expenditure: 40000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 34000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 8000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 11000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 8000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 11000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-33.8 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -29100000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -21297000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -9100000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -17200000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -9100000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -26000000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -17200000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 40000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 34000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 8000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 11000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 8000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 11000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-12.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 9 of 11 periods available· newest 2025-12-31
  • Net income: 9 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 9 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 9 of 11 periods available· newest 2025-12-31
  • Total assets: 9 of 11 periods available· newest 2025-12-31
  • liabilities: No compatible figures in this window
  • Current assets: 9 of 11 periods available· newest 2025-12-31
  • Current liabilities: 9 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 8.32 million

    Prior period

    −USD 24.44 million

    –

    Current period

    −USD 32.77 million

    –

    Exact inputs and evidence

    -32766000 − -24444000 = -8322000 USD

    -24444000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -32766000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 7.02 million

    Prior period

    −USD 22.08 million

    –

    Current period

    −USD 29.1 million

    –

    Exact inputs and evidence

    -29100000 − -22076000 = -7024000 USD

    -22076000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -29100000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +60%

    Prior period

    USD 25,000

    –

    Current period

    USD 40,000

    –

    Exact inputs and evidence

    40000 − 25000 = 15000 USD

    25000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    40000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2017 2017-01-01 – 2017-12-31
−USD 4.26 million
Exact value

Exact value: -4260000 USD

2017-01-01 – 2017-12-31: -4260000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.9 million
Exact value

Exact value: -3900000 USD

2017-01-01 – 2017-12-31: -3900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 22,000
Exact value

Exact value: 22000 USD

2017-01-01 – 2017-12-31: 22000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.92 million
Calculation and evidence

-3900000 − 22000 USD

Exact free cash flow: -3922000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 5.73 million
Exact value

Exact value: -5734000 USD

2018-01-01 – 2018-12-31: -5734000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.7 million
Exact value

Exact value: -5696000 USD

2018-01-01 – 2018-12-31: -5696000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 50,000
Exact value

Exact value: 50000 USD

2018-01-01 – 2018-12-31: 50000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.75 million
Calculation and evidence

-5696000 − 50000 USD

Exact free cash flow: -5746000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 10.65 million
Exact value

Exact value: -10649000 USD

2019-01-01 – 2019-12-31: -10649000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.1 million
Exact value

Exact value: -9102000 USD

2019-01-01 – 2019-12-31: -9102000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2,000
Exact value

Exact value: 2000 USD

2019-01-01 – 2019-12-31: 2000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.1 million
Calculation and evidence

-9102000 − 2000 USD

Exact free cash flow: -9104000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 12.29 million
Exact value

Exact value: -12292000 USD

2020-01-01 – 2020-12-31: -12292000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.19 million
Exact value

Exact value: -9185000 USD

2020-01-01 – 2020-12-31: -9185000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 47,000
Exact value

Exact value: 47000 USD

2020-01-01 – 2020-12-31: 47000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.23 million
Calculation and evidence

-9185000 − 47000 USD

Exact free cash flow: -9232000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 13.59 million
Exact value

Exact value: -13592000 USD

2021-01-01 – 2021-12-31: -13592000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.25 million
Exact value

Exact value: -12252000 USD

2021-01-01 – 2021-12-31: -12252000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 22,000
Exact value

Exact value: 22000 USD

2021-01-01 – 2021-12-31: 22000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.27 million
Calculation and evidence

-12252000 − 22000 USD

Exact free cash flow: -12274000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 13.68 million
Exact value

Exact value: -13676000 USD

2022-01-01 – 2022-12-31: -13676000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.51 million
Exact value

Exact value: -11511000 USD

2022-01-01 – 2022-12-31: -11511000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 81,000
Exact value

Exact value: 81000 USD

2022-01-01 – 2022-12-31: 81000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.59 million
Calculation and evidence

-11511000 − 81000 USD

Exact free cash flow: -11592000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 19.38 million
Exact value

Exact value: -19381000 USD

2023-01-01 – 2023-12-31: -19381000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.73 million
Exact value

Exact value: -18728000 USD

2023-01-01 – 2023-12-31: -18728000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 24,000
Exact value

Exact value: 24000 USD

2023-01-01 – 2023-12-31: 24000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.75 million
Calculation and evidence

-18728000 − 24000 USD

Exact free cash flow: -18752000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 24.44 million
Exact value

Exact value: -24444000 USD

2024-01-01 – 2024-12-31: -24444000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.08 million
Exact value

Exact value: -22076000 USD

2024-01-01 – 2024-12-31: -22076000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 25,000
Exact value

Exact value: 25000 USD

2024-01-01 – 2024-12-31: 25000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.1 million
Calculation and evidence

-22076000 − 25000 USD

Exact free cash flow: -22101000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 32.77 million
Exact value

Exact value: -32766000 USD

2025-01-01 – 2025-12-31: -32766000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29.1 million
Exact value

Exact value: -29100000 USD

2025-01-01 – 2025-12-31: -29100000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 40,000
Exact value

Exact value: 40000 USD

2025-01-01 – 2025-12-31: 40000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29.14 million
Calculation and evidence

-29100000 − 40000 USD

Exact free cash flow: -29140000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 1,849 latest values · 1,849 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001401040, 1401040, DMAC, dmac, edgar:1401040

Also known as DIAMEDICA THERAPEUTICS INC, DIAMEDICA THERAPEUTICS INC., DiaMedica Inc., DiaMedica Therapeutics Inc.